Top-Analysts PicksInvest alongside the top 15% of Wall Street analysts.

Try Top-Picks
Intellia Therapeutics, Inc. Banner

Intellia Therapeutics, Inc.

NTLA Stock Analysis

Page title

Section title

Breakdown
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
Net Income
-14.308m-12.397m-31.634m-67.543m-85.343m-99.533m-134.231m-267.892m-474.186m-481.192m
Depreciation & Amortization
4.500K328.000K1.104M2.994M4.464M5.587M6.311M6.891M7.572M8.976M
Change in Working Capital
1.032M10.001M59.911M-16.215m3.177M-20.661m57.532M-22.904m-53.873m-52.452m
Operating Cash Flow
-3.483m-1.763m36.109M-65.276m-61.257m-103.240m-49.912m-225.030m-333.287m-394.086m
Capital Expenditure
-412.500k-2.554m-6.165m-10.091m-6.358m-6.794m-3.585m-12.756m-58.390m-13.985m
Free Cash Flow
-3.895m-4.317m29.944M-75.367m-67.615m-110.034m-53.497m-237.786m-391.677m-408.071m
Debt Repayment
0.0000.0000.0000.0000.0000.0000.0000.0000.0000.000
Dividends Paid
0.0000.0000.0000.0000.0000.0000.0000.0000.0000.000
Common Stock Issued
0.00074.059M167.904M141.000M28.971M72.256M358.648M736.688M565.789M119.795M
Common Stock Repurchased
0.000-2.671m-100.000k0.0000.0000.0000.0000.0000.0000.000
Net Change in Cash
14.768M65.971M197.248M67.614M-281.822m-1.630m107.380M-39.120m409.977M-295.110m